KaliVir Immunotherapeutics has dosed the first subject in a Phase I/Ib clinical trial for its new oncolytic immunotherapy, ...

The Costume Institute of the Metropolitan Museum of Art is finally addressing the politics of race relations.

According to the report presented to the board, DHD No. 10 is developing a two year plan to disperse the opioid settlement ...

Franklin County is moving forward with changes to a popular, but costly benefits program. Commissioners are hoping the move ...

Cas9, a technology that has moved from lab to clinic at lightning speed. Scientists have already used gene editing to improve ...

Portland-based Disability Rights Oregon has sent two letters to Grants Pass officials, saying its new rules on homeless ...

Select Water Solutions has shown strong growth, driven by increased demand for water treatment and disposal in the Permian ...

Non-slip decks are vital for safe sailing, with a wide range of long-lived, and sustainable coverings available. Jake ...

She, who says Alice Guo is a spy, extended his crime gang to the Philippines. 'We are in no way exculpating them from any ...

Anakalusugan Rep. Ray Reyes committed to continue the party-list's push for free healthcare as he submitted the party-list's Certificate of Nomination and ...

KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy therapeutics, today announced that the first patient ...

If cinema is like dreaming with our eyes open, then horror movies could rightly be viewed as waking nightmares: an ...